EDITORIAL POLICY AND GENERAL INFORMATION "Polish Journal of Endocrinology", hereinafter referred to as PE or ‘the Journal� is the official journal of several working groups of the Polish Society of Endocrinology. The Journal publishes:
- original works,
- review articles,
- case reports,
- letters.
Moreover, book reviews, editorial comments, reports of conventions and meeting announcements are published. The PE editors endorse the principles embodied in the Helsinki Declaration and expect all research involving humans to be conducted in accordance with these principles. For animal experimentation reported in the Journal, it is expected that investigators will have observed the Interdisciplinary Principles and Guidelines for the Use of Animals in Research, Testing and Education issued by the New York Academy of Sciences�Ad Hoc Committee on Animal Research. Adherence to these principles should be indicated in the text of manuscript. All human and animal research must have been approved by the local ethical committee, which should also be indicated in the manuscript. The information that all participants gave a written informed consent should be included in the text.
The review process Manuscripts submitted for publication in PE are evaluated as to whether they present new insights into the announced topic and are likely to contribute to the progress in research or to changes in clinical practice. Received manuscripts are initially examined by the PE editors. Incomplete submissions or manuscripts not prepared in the required style (see below) are sent back to the authors without a scientific review. If manuscript is accepted for review, the authors will be notified in a letter giving the reference number for further correspondence with the Editorial Office. The registered manuscripts are sent to outside reviewers. We encourage authors to suggest the names of possible reviewers but we reserve the right of final selection. Submitted papers are accepted for publication after a positive opinion has been returned by the independent reviewers.
Conflict of interest Authors of research articles should disclose at the time of submission any financial arrangement they may have with a company whose product figures prominently in the submitted manuscript or with a company making a competing product. Such information will be held in confidence while the paper is under review and will not influence the editorial decision, but if the article is accepted for publication, the editors will usually discuss with the authors the manner in which such information is to be communicated to the reader.
Journal policy requires that reviewers, associate editors, editors, and senior editors reveal in a letter to the Editor-in-Chief any relationships that they have that could be construed as causing a conflict of interest with regard to the manuscript under review. The letter should include a statement of any financial relationships with commercial companies involved with a product under study.
Permissions Materials previously published should be accompanied by a written consent for reprinting both from the relevant Publishers and the original authors. If it is possible to identify a patient from a case report, illustration or paper, etc. his/her written consent should be provided prior to publication.
Copyright transfer In sending the manuscript the author(s) confirm(s) that (s)he has they have not previously submitted it to another journal (expect for abstracts of no more than 400 words) or published it elsewhere. The author(s) also agree(s), if and when the manuscript is accepted for publication, to automatic and free transfer of copyright to the Publisher allowing for publication and distribution of the material submitted in all available forms and fields of exploitation (in accord with article 50 of the copyright act and related rights, including multimedia and distribution through teleinformatic networks). The author(s) accept(s) that the manuscript will not be published elsewhere in any language without the written consent of the copyright holder, i.e. the Publisher.
Disclaimer Every effort is made by the Publisher and Editorial Board to see that no inaccurate or misleading data, opinion or statement appear in PE. However, they wish to make it clear that the data and opinions appearing in the articles and advertisements herein are the responsibility of the respective contributor, sponsor or advertiser. Accordingly, the Publisher and the Editorial Board accept no liability whatsoever for the consequences of any such inaccurate of misleading data, opinion or statement. Every effort is made to ensure that drug doses and other quantities are presented accurately. Nevertheless, readers are advised that methods and techniques involving drug usage and other treatments described in the Journal, should only be followed in conjunction with the drug or treatment manufacturer’s own documentation as published in the country of the reader.
PREPARATION OF MANUSCRIPTS Manuscript (if submitted traditionally) should be typed on white bond paper. Margins should be no less than 3 cm. Double spacing should be used throughout the manuscript including the following sections, each of which should begin on a separate sheet: title page, summary and key words, text, acknowledgements, references, individual tables and figures. Pages should be numbered consecutively, beginning with the title page. Abbreviations, if used, should be defined on their first appearance in the text and those not accepted by international bodies should be avoided. English is preferred in original works.
Submitted manuscripts should have the following structure
Original works Title page. The title page should carry the full title of the paper and a short title, consisting of not more than 40 characters including spaces, to be used as a running head (and which should be so identified). The first name, middle initial and last name of each author should appear. If the work is to be attributed to a department or institution, its full name should be included. The name, address and telephone/fax number of the author responsible for correspondence concerning the manuscript should appear on the title page. The title page should include the affiliations of the authors and the sources of any support for the work in the form of grants, equipment or drugs.
Abstracts. Provide on a separate page an abstract of not more than 250 words. Articles containing original data should include a structured abstract with the following four paragraphs, labeled:
Background, Material and methods, Results, and
Conclusions. The abstract should be followed by a list of 3-10 key words or short phrases. When possible, the terms used should be from the Medical Subject Headings list of the Index Medicus.
Text. Full papers of an experimental or observational nature may be usefully divided into sections headed:
Introduction, Material and methods, Discussion and Conclusions. Case report Title page. Similarly as original works.
Text. The succinct description of the case and the results of investigations (images, laboratory tests etc.) should be performed as a table if possible,. The initial diagnosis, differential diagnosis, confirmed diagnosis with pathomorphological diagnosis (biopsy or autopsy), references and short abstract are in Polish and English.
Review articles Editorial Board usually orders review articles. It is possible to publish works, that have not been ordered but it should earlier be consulted with Editor.
Title page. Similarly as original works.
Abstracts should be included
Text. PE editors prefers manuscripts based upon systematic and qualified analysis of available literature. Such reviews should have the following structure:
Background (defining aim of review and clinical problem) and
Conclusions. The rest of subtitles should reflect the logic structure of the work conception. Do not exceed the allowed space for a specific type of article: original article - 3000 words, review article - 6000 words, case report - 1500 words, letters - 1000 words (not including abstract, tables and references).
References References must be triple-spaced and numbered consecutively as they are cited. The style of references is that of Index Medicus.
Journals. List consecutive reference number, list all authors when there are six or fewer; when there are seven or more, list the first three, then "et al." list title, journal title (abbreviated according to Index Medicus), year, volume (Arabic numerals), first and last page. Numbered references to personal communication, unpublished data, and manuscripts either "in preparation" or "submitted for publication" are unacceptable. If essential, such material may be incorporated in the appropriate place in the text. The following is a sample reference:
Example Wiren L, Johannsson G, Bengtsson BA. A prospective investigation of quality of life and psychological well-being after the discontinuation of GH treatment in adolescent patients who had GH deficiency during childhood. J Clin Endocrinol Metab 2001; 86: 3494-4398.
Books. List consecutive reference number, last name and initial(s) of the author(s)/editor(s), title, the editor, place and year of publication.
Example (book references): Arendt J. Melatonin and the mammalian pineal gland. Chapman and Hall, London 1995.
Chapter of book. Reference to a specific chapter should include: last name and initials of its author(s), chapter title, last name and initials of the book author(s)/editor(s), title, the editor, place and year of publication and pages.
Example (book chapter): Kauffman JM, Vermeulen A. Androgens in male senescence. W: Nieschlag E, Behre HM, red. Testosterone, action, deficiency, substitution. Springer, Berlin 1998; 437-471.
Tables and illustrations. Tables and illustrations (numbered, black and white) must be prepared on separate pages. Black and white glossy prints (two copies 13 x 18 cm up to 15 x 20 cm) should be of quality sufficient to maintain desired details with twofold decrease in size. Prints should be submitted with numbers on the back according to their order in the text, and labeled with author’s name, a short title of the paper and the indication of the top of the figure. Description to the figures should be provided on separate pages. Written permission from publishers for any figure previously published must be submitted with the initial manuscript.
Text files. Authors are requested to process text with any of the commonly used text editors. Standard fonts are advised, 12-point typeface.. Please indicate the format and the name of software used.
SENDING THE MANUSCRIPT TO THE JOURNAL All articles should be submitted to EP electronically online at
http://ep.e-manuscripts.viamedica.pl, where detailed instruction regarding submission process will be provided. Alternatively, till the end of 2008, traditional submissions are acceptable ( i.e.either as an e-mial attachment or 3 (three) printed copies of the manuscript along with a corresponding number of tables, pictures and photo duplicates and a computer diskette.
Author should give a e-mail address. All manuscripts submitted should be accompanied by a covering letter including signed confirmation that:
- work has not been published or submitted elsewhere as defined earlier in this document;
- manuscript has been approved by all co-authors (if any), as well as by the responsible authorities at the institution where the work has been carried out;
- author(s) agree(s) to the automatic and free copyright transfer to the Publisher, if and when the work is accepted for publication;
- all sources of financial support have been fully disclosed;
- author(s) confirm(s) that (s)he is (they are) familiar with and will observe the Editorial Policy and Information for Authors included in “Polish Journal of Endocrinology�
- author(s) agree(s) to accept appropriate invoice from the Publisher in case color illustrations are implemented.
The covering letter formula can be found at:
www.endokrynologia.polska.viamedica.pl Correspondence address: Beata Kos-Kudła, M.D., Ph.D.
Editor-in-Chief
"Endokrynologia Polska - Polish Journal of Endocrinology"
Department of Pathophysiology and Endocrinology
Medical University of Silesia
Pl. Traugutta 2, 41-800 Zabrze
tel./fax: (032) 278 61 26
e-mail: endopat@sum.edu.pl
